CSNK2A1 and cervical carcinoma: In summary, these studies demonstrate that the activity of the E7 CKII phospho-acceptor site remains functional and relevant in cells derived from cervical cancers and indicates that the CKII phospho-acceptor site remains a very attractive candidate target for therapeutic intervention in HPV-induced malignancy.